Belviq Lawsuit

Medication Belviq (Lorcaserin) and Increased Risk of Cancer

In February 2020, after studies linked the weight loss drug Belviq to an increased risk of several types of cancer, the sale of Belviq was discontinued and the drug was withdrawn from the U.S. Market. If you have taken Belviq/Belviq XR and were diagnosed with cancer, contact us for a free case evaluation.

About Belviq (Lorcaserin)

Lorcaserin (generic name) is a prescription weight loss pill prescribed for obese or overweight patients and was approved by the FDA in 2012. Lorcaserin is available as both a tablet (Belviq) and an extended-release version (Belviq XR). Lorcaserin works by increasing feelings of fullness so that less food is eaten.

Increased Risk of Cancer

In 2012, the FDA required the manufacturer of Belviq, Eisai, Inc., to perform a clinical trial evaluating the cardiovascular risk of the medication.

While reviewing the safety data from the five-year trial, the FDA found that more patients taking the medication were diagnosed with cancer compared to those taking a placebo. [2]

January 14, 2020: FDA Drug Safety Communication

“The U.S. Food and Drug Administration (FDA) is alerting the public that results from a clinical trial assessing safety show a possible increased risk of cancer with the weight management medicine Belviq, Belviq XR (lorcaserin).” [1]

February 12, 2020: Belviq and Belviq XR Withdrawn from the U.S. Market

Eisai, Inc. announced it would voluntarily withdraw Belviq and Belviq XR from the U.S. market and discontinue sales of the drug. This was following a request from the FDA based on the data analysis of the safety clinical trial, which indicated an increased occurrence of cancer. [3]

Types of Cancer Related to Belviq

According to the FDA analysis of the clinical trial, a range of cancer types was reported, with certain cancers occurring more frequently in the Belviq group, including:

  • Pancreatic cancer
  • Colorectal cancer
  • Lung cancer [3]

Get Help Today

If you or someone you know has taken Belviq/Belviq XR and has been diagnosed with pancreatic, colorectal or lung cancer, you may be entitled to compensation. Click, Chat or call 1800LAW1010 24/7 to determine what legal action you may take related to this dangerous drug.

Don’t Wait Call Today!

We Get Results

[1] U.S. Food & Drug Administration (2020, January 14). Belviq, Belviq XR (lorcaserin): Drug Safety Communication – Due to Possible Increased Risk of Cancer. Retrieved from https://www.fda.gov/safety/medical-product-safety-information/belviq-belviq-xr-lorcaserin-drug-safety-communication-due-possible-increased-risk-cancer

[2] U.S. Food & Drug Administration (2020, January 14). Safety clinical trial shows possible increased risk of cancer with weight-loss medicine Belviq, Belviq XR (lorcaserin). Retrieved from https://www.fda.gov/media/134174/download

[3] U.S. Food & Drug Administration (2020, February 13). FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market. Retrieved from https://www.fda.gov/drugs/drug-safety-and-availability/fda-requests-withdrawal-weight-loss-drug-belviq-belviq-xr-lorcaserin-market